Jorgen B. Jespersen

Esbjerg O, 6705, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

A qualitative study of healthy ageing and co-production.

A qualitative study of healthy ageing and co-production.

Journal: Scientific reports

Published: May 16, 2024

Co-Creation and Co-Production of Health Promoting Activities Addressing Older People-A Scoping Review.

Co-Creation and Co-Production of Health Promoting Activities Addressing Older People-A Scoping Review.

Journal: International journal of environmental research and public health

Published: August 31, 2022

Status and perspectives of biomarker validation for diagnosis, stratification, and treatment.

Status and perspectives of biomarker validation for diagnosis, stratification, and treatment.

Journal: Public health

Published: September 01, 2020

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.

International collaborative study for the calibration of proposed International Standards for thromboplastin, rabbit, plain, and for thromboplastin, recombinant, human, plain.

Journal: Journal of thrombosis and haemostasis : JTH

Published: August 21, 2017

Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.

Fibrin clot structure - pro-fibrinolytic effect of oral contraceptives in apparently healthy women.

Journal: Thrombosis and haemostasis

Published: October 05, 2016

Effectiveness and safety of vitamin K-antagonists in an anticoagulant clinic.

Effectiveness and safety of vitamin K-antagonists in an anticoagulant clinic.

Journal: Thrombosis research

Published: August 19, 2016

Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study: comment.

Impact of point-of-care international normalized ratio monitoring on quality of treatment with vitamin K antagonists in non-self-monitoring patients: a cohort study: comment.

Journal: Journal of thrombosis and haemostasis : JTH

Published: June 06, 2016

Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.

Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease.

Journal: Thrombosis and haemostasis

Published: September 05, 2015

Gender Differences in Fibrin Polymerization and Lysability of Fibrin in Patients with Atrial Fibrillation.

Gender Differences in Fibrin Polymerization and Lysability of Fibrin in Patients with Atrial Fibrillation.

Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Published: August 05, 2015

Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation.

Lysability of fibrin clots is a potential new determinant of stroke risk in atrial fibrillation.

Journal: Thrombosis research

Published: April 23, 2014

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel.

Non-vitamin K antagonist oral anticoagulants (NOACs): No longer new or novel.

Journal: Thrombosis and haemostasis

Published: March 10, 2014

Warfarin or dabigatran for treatment of atrial fibrillation.

Warfarin or dabigatran for treatment of atrial fibrillation.

Journal: Journal of thrombosis and haemostasis : JTH

Published: January 23, 2014

Showing 1-12 of 29

Last Updated: 09/26/2026